Modulation by dantrolene of endotoxin-induced interleukin-10, tumour necrosis factor-α and nitric oxide production in vivo and in vitro

British Journal of Pharmacology

Volumn 124, Issue 6, 1998, Pages 1099-1106

  Haskó, György ^a   Szabó, Csaba ^a,b   Németh, Zoltán H ^a   Lendvai, Balázs ^a   Vizi, E Sylvester ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Interleukin 10; Intracellular calcium; Lipopolysaccharide; Nitric oxide; Tumour necrosis factor

Indexed keywords

CALCIUM ION; DANTROLENE; DIRECTLY ACTING MUSCLE RELAXANT; ENDOTOXIN; FURA 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; CYTOPLASM; ENDOTOXEMIA; INFLAMMATORY DISEASE; INTRAPERITONEAL DRUG ADMINISTRATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK; SHOCK;

ANIMALS; BIOLOGICAL TRANSPORT; CALCIUM; CELL LINE; CELL NUCLEUS; DANTROLENE; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NITRATES; NITRIC OXIDE; NITRITES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031853543     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701934     Document Type: Article

References (48)

1. ADEREM, A.A. & COHN, Z.A. (1988). Calcium ionophore synergizes with bacterial lipopolysaccharides in activating macrophage arachidonic acid metabolism. J. Exp. Med., 167, 623-631.
2. BALDWIN, T.J., WARD, W., AITKEN, A., KNUTTON, S. & WILLIAMS, P.H. (1991). Elevation of intracellular free calcium levels in HEp-2 cells infected with enteropathogenic Eschericia coli. Infect. Immunol, 59, 1559-1604.
3. BARSIG, J., KÜSTERS, S., VOGT, K., VOLK, H.-D., TIEGS, G. & WENDEL, A. (1995). Lipopolysaccharide-induced interleukin-10 in mice: role of endogenous tumor necrosis factor-α. Eur. J. Immunol., 25, 2888-2893.
4. BERG, D.J., KÜHN, R., RAJEWSKY, K., MÜLLER, W., MENON, S., DAVIDSON, N., GRÜNIG, G. & RENNICK, D. (1995). Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J. Clin. Invest., 96, 2339-2347.
5. BEUTLER, B. (1995). TNF, immunity and inflammatory disease: lessons of the past decade. J. Invest. Med., 43, 227-235.
6. BOSSON, S., KUENZIG, M. & SCHWARTZ, S.I. (1985). Verapamil improves cardiac function and increases survival in canine E. coli endotoxin shock. Circ. Shock, 16, 307-316.
7. BUCHMÜLLER-ROUILLER, Y. & MAUEL, J. (1991). Macrophage activation for intracellular killing as induced by calcium ionophore: correlation with biologic and biochemical events. J. Immunol., 146, 217-223.
8. 2+ signalling system in rat enterocytes by heat stable enterotoxin of Eschericia coli. Biochim. Biophys. Acta, 1267, 131-133.
9. CLOWES, G.H.A. (1988). Stresses, mediators, and responses of survival. In Trauma, Sepsis, and Shock, ed. Clowes, G.H.A. pp. 1-53. New York: Dekker.
10. DRYSDALE, B.-E., YAPUNDICH, R.A., SHIN, M.L. & SHIN, H.S. (1987). Lipopolysaccharide-mediated macrophage activation: the role of calcium in the generation of tumoricidal activity. J. Immunol., 138, 951-956.
11. ELENKOV, I.J., HASKÓ, G., KOVÁCS K.J. & VIZI, E.S. (1995). Modulation of lipopolysaccharide-induced tumor necrosis factor-α production by selective α- and β-adrenergic drugs in mice. J. Neuroimmunol., 61, 123-131.
12. FIORENTINO, D.F., ZLOTNIK, A., MOSMANN, T.R., HOWARD, M. & O'GARRA, A. (1991). IL-10 inhibits cytokine production by activated macrophages. J. Immunol., 147, 3815-3822.
13. GORECKA-TISERA, A.M., SNOWDOWNE, K.W. & BORLE, A.B. (1986). Implications of a rise in cytosolic free calcium in the activation of RAW-264 macrophages for tumor cell killing. Cell. Immunol., 100, 411-421.
14. GOTO, M., ZELLER, W.P., LICHTENBERG, R.C. & HURLEY, R.M. (1992). Diltiazem treatment of endotoxic shock in suckling rats. J. Lab. Clin. Med., 120, 465-470.
15. HAINAUT, K.H. & DESMEDT, J.E. (1974). Effect of dantrolene sodium on calcium movements in single muscle fibres. Nature. 252, 728-730.
16. 2-adrenoreceptors on plasma levels of tumour necrosis factor-α, interleukin-6 and corticosterone induced by bacterial lipopolysaccharide in mice. J. Endocrinol., 144, 457-462.
17. HASKÓ, G., SZABÓ, C., MERKEL, K., BENCSICS, A., ZINGARELLI, B., KVETAN, V. & VIZI, E.S. (1996a). Modulation of lipopolysaccharide-induced tumor necrosis factor-α and nitric oxide production by dopamine receptor agonists and antagonists in mice. Immunol. Lett., 49, 143-147.
18. HASKÓ, G., SZABÓ, C., NÉMETH, Z.H., KVETAN, V., PASTORES, S.M. & VIZI, E.S. (1996b). Adenosine receptor agonists differentially regulate IL-10, TNF-α and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J. Immunol., 157, 4634-4640.
19. HASSANAIN, H.H., DAI, W. & GUPTA, S.L. (1993). Enhanced gel mobility shift assay for DNA-binding factors. Anal. Biochem., 213, 162-167.
20. HAUSCHILDT, S., WOLF, B., LÜCKHOFF, A. & BESSLER, W.G. (1990). Determination of second messengers and protein kinase C in bone marrow derived macrophages stimulated with a bacterial lipopeptide. Mol. Immunol., 27, 473-479.
21. HOTCHKISS, R.S. & KARL, I. (1994). Dantrolene ameliorates the metabolic hallmarks of sepsis in rats and improves survival in a mouse model of endotoxemia. Proc. Natl. Acad. Sci. U.S.A, 91, 3039-3043.
22. HOTCHKISS, R.S. & KARL, I.E. (1996). Calcium: a regulator of the inflammatory response in endotoxemia and sepsis. New Horizons, 4, 58-71.
23. HOTCHKISS, R.S., OSBORNE, D.F., LAPPAS, G.D. & KARL, I.E. (1995). Calcium antagonists decrease plasma and tissue concentrations of tumor necrosis factor-α, interleukin-1β, and interleukin-1α in a mouse model of endotoxin. Shock, 3, 337-342.
24. KAMBAYASHI, T., JACOB, C.O., ZHOU, D., MAZUREK, N., FONG, M. & STRASSMANN, G. (1995). Cyclic nuleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-α and IL-6 release by endotoxin-stimulated macrophages. J. Immunol., 155, 4909-4916.
25. LE, J.M. & VILCEK, J. (1989). Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab. Invest., 61, 588-602.
26. LETARI, O., NICOSIA, S., CHIAVAROLI, C., VACHER, P. & SCHLEGEL, W. (1991). Activation by bacterial lipopolysaccharide causes changes in the cytosolic free calcium concentration in single peritoneal macrophages. J. Immunol., 147, 980-983.
27. MARCHANT, A., BRUYNS, C., VANDENABEELE, P., DUCARME, M., GERARD, C. DELVAUX, A., DE GROOTE, D., ABRAMOWICZ, D., VELU, T. & GOLDMAN, M. (1994). Interleukin-10 controls interferon-γ and tumor necrosis factor production during experimental endotoxemia. Eur. J. Immunol., 24, 1167-1171.
28. MAUDSLEY, D.J. & MORRIS, A.G. (1987). Rapid intracellular calcium changes in U937 monocyte cell line: transient increases in response to platelet-activating factor and chemotactic peptide but not interferon-γ or lipopolysaccharide. Immunology, 61, 189-194.
29. MEISEL, C., VOGT, K., PLATZER, C., RANDOW, F., LIEBENTHAL, C. & VOLK, H.-D. (1996). Differential regulation of monocytic tumor necrosis factor-α and interleukin-10 expression. Eur. J. Immunol., 26, 1580-1586.
30. MOSMANN, T.R. (1994). Properties and functions of interleukin-10. Adv. Immunol., 56, 1-26.
31. MÜLLER, J.M., ZIEGLER-HEITBROCK, H.W.L. & BAEUERLE, P.A. (1993). Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology, 187, 233-256.
32. NATH, A., PADUA, R.A. & GEIGER, J.D. (1995). HIV-1 coat protein gp120-induced increases in levels of intrasynaptosomal calcium. Brain Res., 678, 200-206.
33. 2+-related hepatocellular alterations during intra-abdominal sepsis. Am. J. Physiol., 263, R553-R558.
34. SAYEED, M.M. & MAITRA S.R. (1987). Effect of diltiazem on altered cellular calcium regulation during endotoxic shock. Am. J. Physiol., 253, R549-R554.
35. 2+: a critical link in the pathophysiology of sepsis? Proc. Natl. Acad. Sci. U.S.A., 90, 3933-3937.
36. 2. J. Exp. Med., 180, 2365-2370.
37. SUTTLES, J., GIRI, J.G. & MIZEL, S.B. (1990). IL-1 secretion by macrophages: enhancement of IL-1 secretion and processing by calcium ionophores. J. Immunol., 144, 175-182.
38. SZABÓ, C. (1995). Alterations in nitric oxide production in various forms of circulatory shock. New Horizons, 3, 2-32.
39. SZABÓ, C., HASKÓ, G., NÉMETH, Z.H. & VIZI, E.S. (1997). Calcium entry blockers increase interleukin-10 production in endotoxemia. Shock, 7, 304-307.
40. SZABÓ, C., MITCHELL, J.A., GROSS, S.S., THIEMERMANN, C. & VANE, J.R. (1993a). Nifedipine inhibits the induction of nitric oxide synthase by bacterial lipopolysaccharide. J. Pharmacol. Exp. Ther., 265, 674-680.
41. SZABÓ, C., THIEMERMANN, C. & VANE, J.R. (1993b). Dihydropyridine antagonists and agonists of calcium channels inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophages. Biochem. Biophys. Res. Commun., 196, 825-830.
42. SZABÓ, C., WU, C.C., GROSS, S.S., THIEMERMANN, C., PERRETTI, M. & VANE, J.R. (1993c). Interleukin-1 contributes to the induction of nitric oxide synthase by endotoxin in vivo. Eur. J. Pharmacol., 250, 157-160.
43. THIEMERMANN, C., WU, C.C., SZABÓ, C., PERRETTI, M. & VANE, J.R. (1993). Role of tumour necrosis factor in the induction of nitric oxide synthase in a rat model of endotoxin shock. Br. J. Pharmacol., 110, 177-182.
44. VAN DER POLL, T., BARBER, A.E., COYLE, S.M. & LOWRY, S.F. (1996a). Hypercortisolemia increases plasma interleukin-10 concentrations during human endotoxemia a clinical research center study. J. Clin. Endocrinol. Metab., 81, 3604-3606.
45. VAN DER POLL, T., COYLE, S.M., BARBOSA, K., BRAXTON, C.C. & LOWRY, S.F. (1996b). Epinephrine inhibits tumor necrosis factor-α and potentiates interleukin 10 production during human endotoxemia. J. Clin. Invest., 97, 713-719.
46. WARD, A., CHAFFMAN, M.O. & SORKIN, E.M. (1986). Dantrolene: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity. Drugs, 32, 130-168.
47. ZALOGA, G.P., SAGER, A., BLACK, K.W. & PRIELIPP, R. (1992). Low dose calcium administration increases mortality during septic peritonitis in rats. Circ. Shock, 37, 226-229.
48. ZALOGA, G.P., WASHBURN, D., BLACK, K.W. & PRIELIPP, R. (1993). Human sepsis increases lymphocyte intracellular calcium. Crit. Care Med., 21, 196-202.